View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Gemtuzumab Ozogamicin 3 / Cytarabine 1000 / Daunorubicin 60, Acute Myeloid Leukemia, consolidation, cycle 2
Protocol-ID: 5 V1.0 (Mini), GEMOZO3/CYTA1000/DAUN60, AML, cons., C2Indication(s)
- Acute Myeloid Leukemia (CD33+); ICD-10 C92.0-, C92.5-, C93.0-, C92.8-, C92.6-, C92.7-, C92.9-
Links
- Gemtuzumab Ozogamicin [EMA EPAR]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 16.01.2020